Literature DB >> 20583171

Rhizomelic chrondrodysplasia punctata type 2 resulting from paternal isodisomy of chromosome 1.

Graeme Nimmo1, Sarah Monsonego, Maria Descartes, Judith Franklin, Steven Steinberg, Nancy Braverman.   

Abstract

Rhizomelic chondrodysplasia punctata (RCDP) is an autosomal-recessive disorder resulting from mutations in one of three peroxisomal genes essential for ether lipid biosynthesis, PEX7 (RCDP1), GNPAT (RCDP2), and AGPS (RCDP3). Affected patients have characteristic features including shortening of the proximal long bones, epiphyseal stippling, bilateral cataracts, growth and developmental delays. Whereas the majority of patients have RCDP type 1, around 5% have RCDP type 2 or 3. We identified a patient with RCDP type 2 and an apparent homozygous deletion, c.1428delC, after full sequencing of his GNPAT genes. The father was heterozygous for this mutation, while sequencing of the maternal GNPAT genes revealed only wild-type sequence. Southern analyses performed on parental gDNA did not show evidence of a maternal gene deletion. Amplification and fragment analysis of dinucleotide repeat markers spanning chromosome 1 in the patient and both parents revealed paternal uniparental inheritance. We discuss the potential mechanisms causing uniparental disomy (UPD) in this patient and review the literature on chromosome 1 UPD. The absence of non-RCDP clinical features in this patient was consistent with previous literature supporting the absence of imprinted genes on chromosome 1. This first description of RCDP caused by UPD dramatically changes the parental recurrence risk, highlighting the value of obtaining parental genotypes when the proband has a putative homozygous mutation by sequence analysis. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20583171     DOI: 10.1002/ajmg.a.33489

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

1.  Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysis.

Authors:  Simone Nenci; Valentina Piano; Sara Rosati; Alessandro Aliverti; Vittorio Pandini; Marco W Fraaije; Albert J R Heck; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

2.  Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.

Authors:  Masafumi Noguchi; Masanori Honsho; Yuichi Abe; Ryusuke Toyama; Hajime Niwa; Yoshiteru Sato; Kamran Ghaedi; Ali Rahmanifar; Yousef Shafeghati; Yukio Fujiki
Journal:  J Hum Genet       Date:  2014-05-22       Impact factor: 3.172

3.  CD45-deficient severe combined immunodeficiency caused by uniparental disomy.

Authors:  Joseph L Roberts; Rebecca H Buckley; Biao Luo; Jianming Pei; Alla Lapidus; Suraj Peri; Qiong Wei; Jinwook Shin; Roberta E Parrott; Roland L Dunbrack; Joseph R Testa; Xiao-Ping Zhong; David L Wiest
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 4.  Maternal uniparental isodisomy causing autosomal recessive GM1 gangliosidosis: a clinical report.

Authors:  Jessica E King; Amy Dexter; Inder Gadi; Val Zvereff; Meaghan Martin; Miriam Bloom; Adeline Vanderver; Amy Pizzino; Johanna L Schmidt
Journal:  J Genet Couns       Date:  2014-04-30       Impact factor: 2.537

5.  CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort.

Authors:  Sara Ciullini Mannurita; Marina Vignoli; Lucia Bianchi; Anuela Kondi; Valeria Gerloni; Luciana Breda; Rebecca Ten Cate; Maria Alessio; Angelo Ravelli; Fernanda Falcini; Eleonora Gambineri
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

6.  In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Greg Ehrmantraut; Wei Jin; Wei Cui; Nancy E Braverman; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-10-18       Impact factor: 3.876

7.  Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.

Authors:  Fabian Dorninger; Alexander Brodde; Nancy E Braverman; Ann B Moser; Wilhelm W Just; Sonja Forss-Petter; Britta Brügger; Johannes Berger
Journal:  Biochim Biophys Acta       Date:  2014-11-15

8.  Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Yuka Aoyama; Toshiyuki Yamamoto; Naomi Sakaguchi; Mika Ishige; Toju Tanaka; Tomoko Ichihara; Katsuaki Ohara; Hiroko Kouzan; Yasutomi Kinosada; Toshiyuki Fukao
Journal:  Int J Mol Med       Date:  2015-04-14       Impact factor: 4.101

9.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

10.  1q25.2-q31.3 Deletion in a female with mental retardation, clinodactyly, minor facial anomalies but no growth retardation.

Authors:  Ping Hu; Yan Wang; Lu-Lu Meng; Ling Qin; Ding-Yuan Ma; Long Yi; Zheng-Feng Xu
Journal:  Mol Cytogenet       Date:  2013-08-06       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.